Improving Participation in Alzheimer's Research for Asian Americans, Native Hawaiians, and Pacific Islanders
Collaborative Approach for Asian Americans, Native Hawaiians, and Pacific Islanders Research and Education (CARE) 2.0
This project aims to expand a registry that helps Asian American, Native Hawaiian, and Pacific Islander individuals join studies about Alzheimer's disease and related memory conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11128819 on NIH RePORTER |
What this research studies
Many Asian American, Native Hawaiian, and Pacific Islander individuals are not included in important health studies, especially for Alzheimer's disease. This project, called CARE 2.0, builds on a successful registry that has already connected thousands of people from these communities with research opportunities. We want to reach even more people and understand what encourages or prevents them from participating in health research. By doing so, we hope to make sure that future treatments and care plans for Alzheimer's are effective for everyone.
Who could benefit from this research
Good fit: Ideal candidates are Asian American, Native Hawaiian, or Pacific Islander adults aged 21 and older who are interested in participating in or learning about Alzheimer's disease and related dementia research.
Not a fit: Patients who are not Asian American, Native Hawaiian, or Pacific Islander may not directly benefit from this specific registry, as its focus is on those communities.
Why it matters
Potential benefit: If successful, this work could lead to more inclusive Alzheimer's research, ensuring that new discoveries and treatments are relevant and beneficial for diverse communities.
How similar studies have performed: The previous version of the CARE registry successfully enrolled over 9,400 participants and referred more than 5,500 to other studies, demonstrating the effectiveness of this approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Park, Van My Ta — University of California, San Francisco
- Study coordinator: Park, Van My Ta
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.